PLUS1
38.93
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Low
31.61
High
43.0797
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Pfizer Inc | PFE | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 38.93 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 38.93 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 38.93 | USD |
Pfizer Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 216.39B | 5.56B | 5.56B | $ 51.75B | $ 13.02B | 2.88 | 23.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 1.44 | 3.70% | - | - |
Pfizer News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/19/2021 | 13:01 | Dow Jones News | Pfizer Up Eighth Consecutive Day, On Track for Longest.. |
| 4/19/2021 | 12:03 | Seeking Alpha | Moderna and BioNTech slide as Fauci predicts resumption of.. |
| 4/19/2021 | 04:51 | Dow Jones News | BioNTech, Pfizer to Supply Additional 100 Million Covid.. |
| 4/16/2021 | 15:37 | Dow Jones News | Vaccine Manufacturing Issues Force Moderna to Cut Supplies.. |
| 4/16/2021 | 12:13 | Seeking Alpha | Moderna cutting vaccine deliveries to Canada, but Pfizer.. |
| 4/16/2021 | 12:13 | Dow Jones News | Pfizer Currently Up 7 Days, on Pace for Longest Winning.. |
| 4/15/2021 | 20:27 | Dow Jones News | Annual Covid-19 Vaccine Booster Shots Likely Needed, Pfizer.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PFE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 37.39 | 38.96 | 36.89 | 38.00 | 33,232,452 | 1.54 | 4.12% |
| 1 Month | 35.82 | 38.96 | 35.25 | 36.76 | 27,102,622 | 3.11 | 8.68% |
| 3 Months | 37.28 | 38.96 | 33.36 | 35.42 | 31,864,111 | 1.65 | 4.43% |
| 6 Months | 37.87 | 43.0797 | 33.36 | 37.12 | 38,654,469 | 1.06 | 2.8% |
| 1 Year | 36.38 | 43.0797 | 31.61 | 36.82 | 32,645,506 | 2.55 | 7.01% |
| 3 Years | 36.50 | 46.47 | 8.00 | 38.10 | 25,951,031 | 2.43 | 6.66% |
| 5 Years | 32.85 | 46.47 | 8.00 | 36.76 | 23,427,541 | 6.08 | 18.51% |
Pfizer Description
| Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor. |
